Contact Person
    Nicole Mastrell

    Event Manager & PA to CEO
    Email: nm@mva.org
    Phone: (M) +45 6141 8634
    Linkedin

    MVA Medtech Network meeting – September 2020

    Medtech network logo

    Welcome to the MVA Medtech Network and our next meeting!

    Predictive toxicology – an accelerator of MDR approval

    The cumulative effects of globalization, rapidly evolving technologies, and emerging areas of science have created unprecedented opportunities and challenges for the medtech industry. The growing market of medtech has created a need for new tools and a more risk based approach to ensure safe products on the market. Breakthroughs in many areas of science are generating new tools and methods that are being incorporated into the science of toxicology. During the past decade, scientists have taken significant steps to upgrade toxicology toolboxes and developed new faster and more human relevant alternative approaches reducing the need for use of animal testing. In order to obtain acceptance of these new toxicology methods a continuous dialogue and feedback among all relevant stakeholders is needed at all stages, from development to implementation, including qualification and acceptance by regulatory authorities. Where does the industry stand today with regards to predictive toxicology such as computational toxicology and new in vitro test methods, and how can these new approaches be used in submissions for MDR approval?

    Medicon Valley Alliance, together with the Steering Committee of the MVA Medtech Network, welcomes you to the 9th MVA Medtech Network meeting. This meeting will focus on discussions and sharing experiences

    With regards to the rising cases of Covid-19 in the region, this meeting will take place online. 

       
    Date: 9th of September, 2020
    Time: 15.00- 16.30
    Host: Medicon Valley Alliance
    Venue: Online – registered participants will receive the link a few days before the meeting

    Sign up

    The Network
    MVA Medtech Network
    gathers the region’s medtech industry to create new partnerships and business opportunities. Joining the network is free of charge but is limited to Medicon Valley Alliance members. However, non-member organizations and companies are welcome to attend one network event to evaluate if being part of the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically allow you to join the medtech network.

    Program

    14.50-15.00 Online platform open for registering participants
     
    15.00-15.10 Welcome
    Petter Hartman, CEO, Medicon Valley Alliance
    15.10-15.30 The toxicologist’s expert view
    Kelly P. Coleman, Distinguished Toxicologist, Medtronic PLC
    15.30-15.40 Computational methods
    Carsten Baun Senholt, CTO, Saxocon
    15.40-15.50 New in vitro test methods for assessment of skin irritation and skin sensitization
    Rose-Marie Jenvert, Product Manager GARD applications, Senzagen
    15.50-16.10 Considerations and points of interest of notified bodies for medical devices with regard to in-silico approaches for toxicological risk assessment
    Julian Kirch, General Essential Modules – TÜV SÜD Product Service GmbH
    16.10-16.20 Testimonial
    Company TBC
    16.20-16.30 Q&A and conclusions
       
       

    Deadline for registration is the 2nd of September, 2020.

    For more information please contact Nicole Mastrell: nm@mva.org

     

    Medicon Valley Medtech Network is managed by In collaboration with